Tchaikapharma High Quality Medicines AD (BUL:THQM)
Bulgaria
· Delayed Price · Currency is BGN · Price in EUR 9.25
+0.75 (8.82%)
At close: Mar 6, 2026
BUL:THQM Income Statement
Financials in millions BGN. Fiscal year is January - December.
Millions BGN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 63.99 | 53.14 | 48.51 | 43.15 | 42.43 | Upgrade
|
| Revenue | 63.99 | 53.14 | 48.51 | 43.15 | 42.43 | Upgrade
|
| Revenue Growth (YoY) | 20.42% | 9.54% | 12.44% | 1.69% | 5.80% | Upgrade
|
| Cost of Revenue | 19.15 | 20.32 | 33.54 | 12.81 | 30.77 | Upgrade
|
| Gross Profit | 44.85 | 32.82 | 14.98 | 30.34 | 11.67 | Upgrade
|
| Selling, General & Admin | 34.31 | 24.73 | 7.33 | 23.99 | 5.68 | Upgrade
|
| Other Operating Expenses | 0.67 | 0.3 | 0.83 | -0.27 | 0.65 | Upgrade
|
| Operating Expenses | 37.86 | 27.55 | 10.97 | 27.29 | 10.21 | Upgrade
|
| Operating Income | 6.99 | 5.27 | 4.01 | 3.05 | 1.46 | Upgrade
|
| Interest Expense | -0.44 | -0.59 | -0.55 | -0.28 | -0.27 | Upgrade
|
| Interest & Investment Income | 0.58 | 0.48 | 0.46 | 0.47 | 0.46 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.09 | -0.01 | -0.07 | -0.06 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.04 | -0.04 | -0.04 | -0.04 | -0.02 | Upgrade
|
| EBT Excluding Unusual Items | 7.09 | 5.03 | 3.87 | 3.13 | 1.56 | Upgrade
|
| Pretax Income | 7.09 | 5.03 | 3.87 | 3.13 | 1.56 | Upgrade
|
| Income Tax Expense | 0.66 | 0.54 | 0.47 | 0.34 | 0.17 | Upgrade
|
| Net Income | 6.43 | 4.49 | 3.4 | 2.79 | 1.4 | Upgrade
|
| Net Income to Common | 6.43 | 4.49 | 3.4 | 2.79 | 1.4 | Upgrade
|
| Net Income Growth | 43.17% | 32.12% | 21.86% | 99.86% | 226.17% | Upgrade
|
| Shares Outstanding (Basic) | 96 | 96 | 93 | 93 | 93 | Upgrade
|
| Shares Outstanding (Diluted) | 96 | 96 | 93 | 93 | 93 | Upgrade
|
| Shares Change (YoY) | - | 3.38% | - | - | 38.72% | Upgrade
|
| EPS (Basic) | 0.07 | 0.05 | 0.04 | 0.03 | 0.02 | Upgrade
|
| EPS (Diluted) | 0.07 | 0.05 | 0.04 | 0.03 | 0.02 | Upgrade
|
| EPS Growth | 43.17% | 27.80% | 21.87% | 99.86% | 135.13% | Upgrade
|
| Free Cash Flow | 2.48 | 1.2 | 0.96 | 0.88 | 0.45 | Upgrade
|
| Free Cash Flow Per Share | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Gross Margin | 70.08% | 61.76% | 30.87% | 70.31% | 27.49% | Upgrade
|
| Operating Margin | 10.92% | 9.92% | 8.26% | 7.06% | 3.43% | Upgrade
|
| Profit Margin | 10.05% | 8.45% | 7.01% | 6.47% | 3.29% | Upgrade
|
| Free Cash Flow Margin | 3.87% | 2.25% | 1.97% | 2.04% | 1.06% | Upgrade
|
| EBITDA | 9.4 | 7.77 | 6.81 | 6.38 | 5.3 | Upgrade
|
| EBITDA Margin | 14.68% | 14.62% | 14.04% | 14.78% | 12.50% | Upgrade
|
| D&A For EBITDA | 2.41 | 2.5 | 2.8 | 3.33 | 3.85 | Upgrade
|
| EBIT | 6.99 | 5.27 | 4.01 | 3.05 | 1.46 | Upgrade
|
| EBIT Margin | 10.92% | 9.92% | 8.26% | 7.06% | 3.43% | Upgrade
|
| Effective Tax Rate | 9.31% | 10.73% | 12.14% | 10.92% | 10.74% | Upgrade
|
| Revenue as Reported | 64.04 | - | - | - | 42.56 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.